We are thrilled to announce that Sanjay Sisodiya has been appointed to the new role of Transformation Director at the ...

Cassava Sciences, Inc. (NASDAQ: SAVA, “Cassava”, the “Company”), a clinical-stage biotechnology company focused on developing novel, investigational treatments for central nervous system (CNS) ...

When Amina Bello Sauna, a 19-year-old, heard about a supposed miracle site in Kano State said to bear the footprint of Prophet Muhammad (peace be upon him), she was overjoyed and convinced that she ...

By Dennis Thompson HealthDay ReporterTHURSDAY, May 1, 2025 (HealthDay News) — A class of drugs used to treat epilepsy, nerve ...

SGLT-2 inhibitor use vs DPP-4 inhibitor use was associated with lower incidence of epilepsy among patients with type 2 diabetes.